Mannan-binding lectin deficiency — Good news, bad news, doesn't matter?
- 30 April 2012
- journal article
- review article
- Published by Elsevier BV in Clinical Immunology
- Vol. 143 (1), 22-38
- https://doi.org/10.1016/j.clim.2011.11.002
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activationImmunobiology, 2010
- A Novel Mannose-binding Lectin/Ficolin-associated Protein Is Highly Expressed in Heart and Skeletal Muscle Tissues and Inhibits Complement ActivationOnline Journal of Public Health Informatics, 2010
- Deficient Serum Mannose‐Binding Lectin Levels andMBL2Polymorphisms Increase the Risk of Single and RecurrentCryptosporidiumInfections in Young ChildrenThe Journal of Infectious Diseases, 2009
- Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donorsBone Marrow Transplantation, 2009
- Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaeniaEuropean Journal of Cancer, 2009
- Donor Mannose‐Binding Lectin Deficiency Increases the Likelihood of Clinically Significant Infection after Liver TransplantationClinical Infectious Diseases, 2009
- Mannan-binding lectin genotypes and genotype–phenotype relationships in a large cohort of Polish neonatesHuman Immunology, 2009
- Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathwayImmunobiology, 2007
- Mannose-Binding Lectin: Clinical Implications for Infection, Transplantation, and AutoimmunityHuman Immunology, 2006
- The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropeniaEuropean Journal of Cancer, 2006